International
Asia Pacific
EMEA
North America
Latin America
The Chairman of Farmindustria, commenting on the data provided by the Italian National Institute of Statistics (Istat), announced that the Italian pharmaceutical sector has exceeded 50 billion euros in production during 2023. Despite a general decrease of 2.5% in Italy's industrial production, the pharmaceutical sector grew by 7.3%, in countertrend to other sectors.
In particular, according to Farmindustria's Chairman, Italy excels in contract production, which accounted for a turnover of EUR 3.1 billion in 2021. Also due to the increase in investments, this segment of production, which stands out for its flexibility, recorded an annual growth of 9%, with more than 80% of turnover generated by exports to foreign markets in the last three years.
However, at the same time, the Chairman of Farmindustria has also analyzed the critical issues of the segment, which are found mainly in relation to operating costs, which have risen by 31% compared to 2021, and dependency in the supply of raw materials, which is worsening in an uncertain geopolitical context characterized by crises and wars.
Copyright © 2024 Baker & McKenzie. All rights reserved. Ownership: This documentation and content (Content) is a proprietary resource owned exclusively by Baker McKenzie (meaning Baker & McKenzie International and its member firms). The Content is protected under international copyright conventions. Use of this Content does not of itself create a contractual relationship, nor any attorney/client relationship, between Baker McKenzie and any person. Non-reliance and exclusion: All Content is for informational purposes only and may not reflect the most current legal and regulatory developments. All summaries of the laws, regulations and practice are subject to change. The Content is not offered as legal or professional advice for any specific matter. It is not intended to be a substitute for reference to (and compliance with) the detailed provisions of applicable laws, rules, regulations or forms. Legal advice should always be sought before taking any action or refraining from taking any action based on any Content. Baker McKenzie and the editors and the contributing authors do not guarantee the accuracy of the Content and expressly disclaim any and all liability to any person in respect of the consequences of anything done or permitted to be done or omitted to be done wholly or partly in reliance upon the whole or any part of the Content. The Content may contain links to external websites and external websites may link to the Content. Baker McKenzie is not responsible for the content or operation of any such external sites and disclaims all liability, howsoever occurring, in respect of the content or operation of any such external websites. Attorney Advertising: This Content may qualify as “Attorney Advertising” requiring notice in some jurisdictions. To the extent that this Content may qualify as Attorney Advertising, PRIOR RESULTS DO NOT GUARANTEE A SIMILAR OUTCOME. Reproduction: Reproduction of reasonable portions of the Content is permitted provided that (i) such reproductions are made available free of charge and for non-commercial purposes, (ii) such reproductions are properly attributed to Baker McKenzie, (iii) the portion of the Content being reproduced is not altered or made available in a manner that modifies the Content or presents the Content being reproduced in a false light and (iv) notice is made to the disclaimers included on the Content. The permission to re-copy does not allow for incorporation of any substantial portion of the Content in any work or publication, whether in hard copy, electronic or any other form or for commercial purposes.
Are you sure want to delete comment ?
Scan this QR Code to share this content
